Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
04/2006
04/06/2006US20060073475 Compositions and methods for detecting pathogenic bacteria expressing chaperonin proteins
04/06/2006US20060073468 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof
04/06/2006US20060073168 contacting an isolated serogroup A meningococcal capsular polysaccharide with an isolated Serogroup A Neisseria meningitidis O-acetyltransferase polypeptide; immunogenic compositions; vaccine for generating a protective immune response to Neisseria meningitidis
04/06/2006US20060073161 Nucleic acid and amino acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
04/06/2006US20060073160 Cloning of chicken anemia virus DNA
04/06/2006US20060073155 Methods and compositions for diseases associated with amyloidosis
04/06/2006US20060073152 Therapeutic agents with decreased toxicity
04/06/2006US20060073148 IL-13 binding agents
04/06/2006US20060073139 Vaccine composition for preventing meningococcal disease
04/06/2006US20060073138 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
04/06/2006US20060073133 Sialoadhesin factor-3 antibodies
04/06/2006US20060073120 IKKalpha and IKKbeta specific inhibitors
04/06/2006US20060073117 Methods and compositions for controlling hair follicle stem cell fate
04/06/2006US20060073115 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis, inflamamatory disorders or infection by microorganisms
04/06/2006DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells
04/06/2006DE102004046116A1 Pullulanasen aus psychrophilen Organismen Pullulanases from psychrophilic organisms
04/06/2006CA2848573A1 Rnai modulation of apob and uses thereof
04/06/2006CA2623830A1 Hematological cancer profiling system
04/06/2006CA2585507A1 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof
04/06/2006CA2582940A1 Myostatin isoform
04/06/2006CA2581469A1 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
04/06/2006CA2580707A1 Rnai modulation of apob and uses thereof
04/06/2006CA2580700A1 Simplified methods for isolating nucleic acids from cellular materials
04/06/2006CA2580661A1 Methods for isolating nucleic acids from biological and cellular materials
04/06/2006CA2580126A1 Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
04/06/2006CA2554718A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
04/05/2006EP1642987A2 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
04/05/2006EP1641944A2 Room temperature elution of nucleic acids
04/05/2006EP1641942A2 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
04/05/2006EP1641940A2 Prognosis determination in ewing sarcoma patients by means of genetic profiling
04/05/2006EP1641934A2 Methods for enhancing gene expression analysis
04/05/2006EP1641925A1 Food additive comprising pseudomonas non-maltogenic exoamylase variants
04/05/2006EP1641809A2 Method and compositions for detection and enumeration of genetic variations
04/05/2006EP1641730A1 Recombined molecules and preparation thereof
04/05/2006EP1641422A2 Interleukin-21 analogs
04/05/2006EP1250463B1 Sensitive, multiplexed diagnostic assays for protein analysis
04/05/2006EP1244667B1 Cyclohexene nucleic acids
04/05/2006EP1102785A4 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
04/05/2006EP1015628B1 A diagnostic test for spinocerebellar ataxia type 6
04/05/2006EP0946188B1 Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
04/05/2006EP0741792B1 Herpesvirus pre-(viral dna replication) enveloped particles
04/05/2006EP0682715B1 Diagnostic assays and kits for detecting rna using rna binary probes and an rna-directed rna ligase
04/05/2006EP0649435B1 Membrane-associated immunogens of mycobacteria
04/05/2006CN1249252C Computer method and system for correlating sequencing data by MS
04/05/2006CN1249240C Expression vector pBVTB, its construction method and use in HCV vaccin research
04/05/2006CN1249238C Nucleotide specific for escherichia coli 0123 O-antigen
04/05/2006CN1249237C Nucleotide peculiar to 0-antigen of 0132 type bacillus coli
04/05/2006CN1249236C Nucleotide specific against 0-antigen of colibacillus 0172
04/05/2006CN1249235C Nucleotide specific against o-antigen of colibacillus 0150
04/05/2006CN1249234C Nucleotide specific to O-antigen of shigella boydii I and Bacillus coli 0149
04/05/2006CN1249214C Substrates for immobilizing and amplifying DNA, DNA-immobilized chips having DNA immobilized on the substrates, and method for amplifying DNA
04/05/2006CN1249082C Apoptosis promoting gene BNIPL, coding albumen and uses thereof
04/04/2006US7024312 Genetic engineering; libraries; computer analyzing
04/04/2006US7022895 Plant amino acid biosynthetic enzymes
04/04/2006US7022835 by contacting with a solution containing a metal salt, polyethylene glycol, buffer and solid with hydrophilic and hydrophobic groups and/or a hydrophilic water-containing polymer matrix; for immobilizing nucleic acids for purification and/or extension; kits for analyte detection
04/04/2006US7022834 nucleotide synthesis; for measuring cellular proliferation and/or destruction rates by measuring DNA synthesis; mammalian cancer cells or cells infected with human immunodeficiency virus (HIV)
04/04/2006US7022833 Process for the preparation of phosphorothioate triesters
04/04/2006US7022832 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma
04/04/2006US7022831 anticode oligomer treatments for inhibiting growth of cancer cells; complementary to mRNA
04/04/2006US7022830 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/04/2006US7022828 Anticancer agents, antiinflammatory agents, autoimmune disease; modulation of gene expression; nuclear factor kappa B
04/04/2006US7022827 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
04/04/2006US7022826 Contains at least one mutation that reduces or eliminates the ability of the fluorescent protein to oligomerize; determining the pH of a sample, presence of an enzyme, and activity of an enzyme by variation of fluorescence; kits
04/04/2006US7022680 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
04/04/2006US7022526 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms
04/04/2006US7022510 Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers
04/04/2006US7022508 using genetically engineered vector and trichoderma host; can be obtained independently of the saponin content of a soybean extract
04/04/2006US7022507 Encoded human mitochondrial protein useful for diagnosing, treating, or preventing disorders associated with expression of mitochondrial proteins, such as disorders of cell proliferation, inflammation, and immune response
04/04/2006US7022498 Designated "PRO444"; fusion proteins, vectors, host cells
04/04/2006US7022488 Functional coupling of T1Rs and T2Rs by Gi proteins, and cells-based assays for the identification of T1R and T2R modulators
04/04/2006US7022479 Detection of preferential biopolymers in sample; obtain sample mixture, incubate with binding reagent, form complexes, isolate bound complexes, amplify and detect signal tags
04/04/2006US7022478 Methods for evaluating stroke or cardiac ischemia by nucleic acid detection
04/04/2006US7022476 Calibrating test pattern; hybrid primers
04/04/2006US7022475 Genetic polymorphisms responsible for altered expression of the cytochrome (cyp3a5); drug metabolism, efficacy and toxicity with respect to anticancer agents and immunosuppressants
04/04/2006US7022473 Substrates for immobilizing and amplifying DNA and DNA-immobilized chips
04/04/2006US7022472 Mutations in human MLH1 and human MSH2 genes useful in diagnosing colorectal cancer
04/04/2006US7022336 Methods for attaching proteins to lipidic microparticles with high efficiency
04/04/2006US7022327 Recombinant birnavirus vaccine
04/04/2006US7022320 Eliciting an immune response by administering a vector construct which comprising a recombinant polynucleotide, able encoding a Mycobacterium tuberculosis antigen in human; administering antigen protein, or live attenuated vaccine; gold core carrier; dna vaccines
04/04/2006CA2316755C Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
03/2006
03/30/2006WO2006034332A2 In vivo incorporation of alkynyl amino acids into proteins in eubacteria
03/30/2006WO2006034321A2 Oligomeric compounds effecting drosha-mediated cleavage
03/30/2006WO2006034264A2 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
03/30/2006WO2006033730A2 Novel polynucleotide synthesis labeling chemistry
03/30/2006WO2006033664A1 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
03/30/2006WO2006033020A2 Methods and apparatus for the detection and validation of micrornas
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006WO2006003638A3 Novel method for labeling nucleic acid in a sequence-specific manner, and method for detecting nucleic acid using the same
03/30/2006WO2006001832A3 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells
03/30/2006WO2005123929A3 Plastid transit peptides
03/30/2006WO2005116265A3 Probe arrays for expression profiling of rat genes
03/30/2006WO2005113779A3 Plant myo-inositol kinase polynucleotides and methods of use
03/30/2006WO2005106009A3 Lactoferrin cleavage of neisserial proteins
03/30/2006WO2005084115A3 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof
03/30/2006WO2005082076A3 Methods for treating breast cancer using nrif3 related molecules
03/30/2006WO2005056795A3 Hif oligonucleotide decoy molecules
03/30/2006WO2005040074A3 Crick-watson base paired dendrimer structures
03/30/2006WO2004096978A3 Production of high mannose proteins in plant culture
03/30/2006WO2004090114A3 Compositions and methods of using a synthetic dnase i
03/30/2006WO2004065579A3 Modified oligonucleotides for use in gene modulation